Loading patent…
OwnerHiroshi Nakamura, Masunori Matsuzaki +1inventors
InventorsHiroshi Nakamura, Masunori Matsuzaki, Tsutomu Yoshida
Estimating the term…
The prior art has problems such as high mortality of model animals due to complication of heart failure, necessity of taking into consideration the effects from other organs for investigation of the mechanism of the disease, being unable to prepare an extensive myocardial infarction model, and others. The invention allows exclusion of the state of heart failure and provides an extensive myocardial infarction model animal which permits to prepare a model of the pathology of extensive myocardial infarction. The invention is an extensive myocardial infarction model animal, the method for preparation thereof, and the method for screening of drugs and/or genes using the model animal, wherein the heart of a normal animal is extirpated, the left main trunk of the extirpated heart is ligated, the heart after the ligation is heterotopically grafted to the abdomen of another normal animal, and the animal given the heterotopic graft is used as the extensive myocardial infarction model animal. Three weeks after the graft, the model of extensive myocardial infarction pathology is established.
1) an extensive myocardial infarction model animal characterized in that the left main trunk of the heart of a normal animal is ligated, followed by heterotopic graft of the heart with the ligated coronary artery to the abdomen of another normal animal, and the animal given heterotopic heart graft is used as the myocardial infarction model animal:
2) An extensive myocardial infarction model animal according to claim (1), characterized in that the ligation of the coronary artery comprises a process of extirpation of the heart of a normal animal and a process of ligation of the left main trunk of the extirpated heart.
3) An extensive myocardial infarction model animal according to claim (1) or claim (2), characterized in that the above-mentioned ligation of the left coronary artery in the proximal segment consists in turning up of the left atrium, followed either by (1) single ligation of the left coronary arterial main trunk (LMT) or by (2) simultaneous ligation of the left anterior descending artery (LAD) in the proximal segment and the left circumflex artery (CX) in the proximal segment.
4) A method for preparation of an extensive myocardial infarction model animal characterized in that the LMT of the heart of a normal animal is ligated in the proximal segment, followed by heterotopic graft of the heart with the ligated coronary artery to the abdomen of another normal animal to prepare a pathological state of myocardial infarction after a specified time after the heterotopic graft.
5) A method for preparation of an extensive myocardial infarction model animal according to claim (4), characterized in that the ligation of the coronary artery comprises a process of extirpation of the heart of a normal animal and a process of LMT ligation of the extirpated heart.
6) A method for preparation of an extensive myocardial infarction model animal according to claim (4) or claim (5), characterized in that the above-mentioned ligation of the LMT consists in turning up of the left atrium, followed either by (1) single ligation of the left coronary arterial main trunk (LMT) or by (2) simultaneous ligation of the left anterior descending artery (LAD) in the proximal segment and the left circumflex artery (CX) in the proximal segment.
7) A method for preparation of an extensive myocardial infarction model animal according to claim (4) or claim (5) or claim (6), characterized in that the above-mentioned specified time is 3 weeks or longer.
8) A method for screening of drugs and/or genes using the extensive myocardial infarction model animal described in any of claim (1) to claim (3) or the extensive myocardial infarction model animal prepared by the method described in any of claim (4) to claim (7).
Dependencies are inferred from the claim text.